Hongyang Wang

34.9k total citations · 7 hit papers
486 papers, 22.0k citations indexed

About

Hongyang Wang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Hongyang Wang has authored 486 papers receiving a total of 22.0k indexed citations (citations by other indexed papers that have themselves been cited), including 247 papers in Molecular Biology, 121 papers in Cancer Research and 93 papers in Oncology. Recurrent topics in Hongyang Wang's work include Cholangiocarcinoma and Gallbladder Cancer Studies (46 papers), RNA modifications and cancer (41 papers) and MicroRNA in disease regulation (37 papers). Hongyang Wang is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (46 papers), RNA modifications and cancer (41 papers) and MicroRNA in disease regulation (37 papers). Hongyang Wang collaborates with scholars based in China, United States and South Korea. Hongyang Wang's co-authors include Lei Chen, Yexiong Tan, Mengchao Wu, Le‐Xing Yu, Jin Ding, Bo Zheng, Yanjing Zhu, Jing Fu, Wen Yang and Liwei Dong and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Hongyang Wang

461 papers receiving 21.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer

2018 779 citations Le‐Xing Yu, Linna Guo et al. profile →
A family of proteins that inhibit signalling through tyrosine kinase receptors

1997 572 citations Hongyang Wang et al. profile →
New knowledge of the mechanisms of sorafenib resistance in liver cancer

2017 530 citations Yanjing Zhu, Bo Zheng et al. profile →
Immune cell profiling of COVID-19 patients in the recovery stageby single-cell sequencing

2020 524 citations Liwei Dong, Xiuliang Cui et al. profile →
The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis

2020 260 citations Hongyang Wang et al. profile →
M6A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma

2021 174 citations Xinyao Qiu, Shuai Yang et al. Cancer Research profile →
TET2-mediated tumor cGAS triggers endothelial STING activation to regulate vasculature remodeling and anti-tumor immunity in liver cancer

2024 62 citations Xiuliang Cui, Hongyang Wang et al. profile →

Peers

Countries citing papers authored by Hongyang Wang

Since Specialization

Citations

This map shows the geographic impact of Hongyang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongyang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongyang Wang more than expected).

Fields of papers citing papers by Hongyang Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongyang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongyang Wang. The network helps show where Hongyang Wang may publish in the future.

Co-authorship network of co-authors of Hongyang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Hongyang Wang. A scholar is included among the top collaborators of Hongyang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongyang Wang. Hongyang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	NADH against noise-induced hearing loss: Evidence from models of "temporary" and "permanent" deafness 2025 ·Hearing Research ·(unknown), (unknown), Jin Li, Danyang Li, Yi Luo, Yuhan Chen, Xiaolong Zhang, Hongyang Wang, Qiuju Wang	0
2	Current status and prospects of targeted therapy for cholangiocarcinoma based on molecular characteristics 2025 ·Cancer Letters ·Xiaoqiang Cui, Teng Huang, Tianyi Jiang, Hongyang Wang	2
3	Dynamics of liver cancer cellular taxa revealed through single-cell RNA sequencing: Advances and challenges 2024 ·Cancer Letters ·Wenxin Li, (unknown), Hongyang Wang, Wen Wen	4
4	Diverse functions of SOX9 in liver development and homeostasis and hepatobiliary diseases 2023 ·Genes & Diseases ·(unknown), Tianyi Jiang, Xiaoqiang Cui, Yufei Pan, (unknown), Liwei Dong, Hongyang Wang	5
5	Molecular mechanisms governing the progression of nephritis in lupus prone mice and human lupus patients 2023 ·Frontiers in Immunology ·(unknown), Hongyang Wang, Prathyusha Bachali, Nan Shen, Kathryn M. Kingsmore, Robert Robl, Amrie C. Grammer, Shu Man Fu, Peter E. Lipsky	3
6	PC3T: a signature-driven predictor of chemical compounds for cellular transition 2023 ·Communications Biology ·(unknown), Bin Song, Peilin Zhang, Zhi Zhong, Yongxiang Zhang, Xiaochen Bo, Hongyang Wang, Yong Zhang, Xiuliang Cui, Wenxia Zhou	1
7	Hepatitis B–Induced IL8 Promotes Hepatocellular Carcinoma Venous Metastasis and Intrahepatic Treg Accumulation 2021 ·Cancer Research ·(unknown), Yanan Gao, (unknown), Geoffrey J. Markowitz, Jing Fu, Zhenxing Zhang, Chunliang Liu, Wenhao Qin, Hongyang Wang, Fan Wang, Pengyuan Yang	56
8	M6A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma breakdown → 2021 ·Cancer Research ·Xinyao Qiu, Shuai Yang, Shan Wang, Jianmin Wu, Bo Zheng, Kaiting Wang, Siyun Shen, Seogsong Jeong, Zhi‐Xuan Li, Yanjing Zhu, Tong Wu, Xuan Wu, Rui Wu, Weiwei Liu, Hongyang Wang, Lei Chen	174
9	Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials 2020 ·Clinical Cancer Research ·Donghua Shi, Yao Shi, Ahmed O. Kaseb, Xingxing Qi, Yuan Zhang, Jiachang Chi, Qing Lü, Huiping Gao, Hua Jiang, Huamao Wang, Daijing Yuan, Hong Ma, Hongyang Wang, Zonghai Li, Bo Zhai	254
10	The HLF/IL-6/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis 2017 ·Gut ·Daimin Xiang, Wen Sun, Beifang Ning, Tengfei Zhou, Xiaofeng Li, Wei Zhong, Zhuo Cheng, Mingyang Xia, Xue Wang, Xing Deng, Wei Wang, Hengyu Li, Xiuliang Cui, Shichao Li, Bin Wu, Wei‐Fen Xie, Hongyang Wang, Jin Ding	181
11	Inflammation-Dependent IL18 Signaling Restricts Hepatocellular Carcinoma Growth by Enhancing the Accumulation and Activity of Tumor-Infiltrating Lymphocytes 2016 ·Cancer Research ·Geoffrey J. Markowitz, Pengyuan Yang, Jing Fu, Gregory Michelotti, Rui Chen, Jianhua Sui, Bin Yang, Wenhao Qin, Zheng Zhang, Fu‐Sheng Wang, Anna Mae Diehl, Qi-Jing Li, Hongyang Wang, Xiaofan Wang	42
12	CYP3A5 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Regulating mTORC2/Akt Signaling 2015 ·Cancer Research ·Feng Jiang, Lei Chen, Yingcheng Yang, Xianming Wang, Ruoyu Wang, Liang Li, Wen Wen, Yan–Xin Chang, Cai–Yang Chen, Jing Tang, (unknown), Wentao Huang, Lin Xu, Hongyang Wang	52
13	Hepatitis B Virus Combo Mutations Improve the Prediction and Active Prophylaxis of Hepatocellular Carcinoma: A Clinic-Based Cohort Study 2015 ·Cancer Prevention Research ·Jianhua Yin, (unknown), Rui Pu, Haiguang Xin, Zixiong Li, Xue Han, Yibo Ding, Yan Du, Wenbin Liu, Yang Deng, (unknown), Ming Wu, Ming‐Lung Yu, Hongwei Zhang, Hongyang Wang, Timothy C. Thompson, Ni Wu, Guangwen Cao	21
14	Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma 2014 ·Clinical Cancer Research ·Huiping Gao, Kesang Li, Hong Tu, Xiaorong Pan, Hua Jiang, Bizhi Shi, Juan Kong, Hongyang Wang, Shengli Yang, Jianren Gu, Zonghai Li	259
15	A Novel EGFR Isoform Confers Increased Invasiveness to Cancer Cells 2013 ·Cancer Research ·Min Zhou, Hai Wang, Keke Zhou, Xiaoying Luo, Xiaorong Pan, Bizhi Shi, Hua Jiang, Jiqin Zhang, Kesang Li, Huamao Wang, Huiping Gao, Shun Lu, Ming Yao, Ying Mao, Hongyang Wang, Shengli Yang, Jianren Gu, Chuan‐Yuan Li, Zonghai Li	20
16	Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue Metabolomics 2013 ·Cancer Research ·Qiang Huang, Yexiong Tan, Peiyuan Yin, Guozhu Ye, Peng Gao, Xin Lu, Hongyang Wang, Guowang Xu	342
17	Prognostic Significance of AMPK Activation and Therapeutic Effects of Metformin in Hepatocellular Carcinoma 2013 ·Clinical Cancer Research ·Longyi Zheng, Wen Yang, Fuquan Wu, Chao Wang, Le‐Xing Yu, Liang Tang, Bijun Qiu, Yuqiong Li, Linna Guo, Meng-Chao Wu, Gen‐Sheng Feng, Dajin Zou, Hongyang Wang	184
18	Gut-Derived Lipopolysaccharide Promotes T-Cell–Mediated Hepatitis in Mice through Toll-Like Receptor 4 2012 ·Cancer Prevention Research ·Yan Lin, Le‐Xing Yu, He‐Xin Yan, Wen Yang, Liang Tang, Hui‐Lu Zhang, Qiong Liu, Shan–Shan Zou, Yaqin He, Chao Wang, Mengchao Wu, Hongyang Wang	33
19	Suppression of Cyclin D1 by Hypoxia-Inducible Factor-1 via Direct Mechanism Inhibits the Proliferation and 5-Fluorouracil–Induced Apoptosis of A549 Cells 2010 ·Cancer Research ·Wen Wen, Jin Ding, Wen Sun, Kun Wu, Beifang Ning, Wenfeng Gong, Guoping He, Shanna Huang, Xinyu Ding, Peipei Yin, Lei Chen, Qiong Liu, Wei‐Fen Xie, Hongyang Wang	69
20	Wnt/β-Catenin Signaling Contributes to Activation of Normal and Tumorigenic Liver Progenitor Cells 2008 ·Cancer Research ·Wen Yang, He‐Xin Yan, Lei Chen, Qiong Liu, Yaqin He, Le‐Xing Yu, Shuhui Zhang, Dandan Huang, Liang Tang, Xiaoni Kong, Chao Chen, Shuqin Liu, Mengchao Wu, Hongyang Wang	306

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact